The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC).

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 2, 2024

Primary Completion Date

December 11, 2025

Study Completion Date

June 30, 2027

Conditions
HER2-positive Breast CancerAdvanced Breast Cancer
Interventions
DRUG

Pyrotinib

Pyrotinib 400mg qd po continuously

DRUG

Trastuzumab

For Trastuzumab, the loading dose for the first treatment cycle is 8 mg/kg, and for subsequent cycles, 6 mg/kg. It is to be used once every three weeks

DRUG

Taxanes

Taxanes: Usual clinical dose is administered, in a 21-day cycle.

DRUG

Capecitabine

Capecitabine: 650mg/m2 each time, given twice daily

Trial Locations (1)

050000

RECRUITING

The Fourth Hospital of Hebei Medical University, Shijiazhuang

All Listed Sponsors
lead

Hebei Medical University Fourth Hospital

OTHER